Asset pricing underestimates physical climate risks, warns DWS
The EUR 700 billion asset manager now incorporates physical climate risk in portfolio construction, so favoring firms with a more climate change-resilient business model. Globally, weather events have already hit share prices on several occasions and new data suggest markets have not yet priced in this risk.
The Caribbean island of Puerto Rico is host to manufacturing plants belonging to some of the world's largest pharmaceutical companies, including US giant Johnson & Johnson, Switzerland's Novartis and the UK and Swedish firm AstraZeneca.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
